Advancing children's health care and outcomes through the pediatric quality measures program

Kamila B Mistry1, Francis Chesley1, Karen LLanos2

  • 1Children's Health Insurance Program Reauthorization Act Pediatric Quality Measures Program, Office of Extramural Research, Education, and Priority Populations, Agency for Healthcare Research and Quality, Rockville, MD.

Academic Pediatrics
|August 30, 2014
PubMed

Insights

The Pediatric Quality Measures Program (PQMP) was established to create evidence-based pediatric quality measures for children

Area of Science:

  • Health Services Research
  • Pediatric Health Quality Measurement

Background:

  • The Children's Health Insurance Program Reauthorization Act (CHIPRA) of 2009 mandated improvements in child health quality measurement.
  • The Agency for Healthcare Research and Quality (AHRQ) partnered with Centers for Medicare & Medicaid Services (CMS) to implement CHIPRA provisions.
  • The establishment of the Pediatric Quality Measures Program (PQMP) was a key initiative under CHIPRA.

Purpose of the Study:

  • To outline the goals and activities of the Pediatric Quality Measures Program (PQMP).
  • To present a portfolio of new and enhanced pediatric quality measures.
  • To inform the improvement of the Child Core Set of quality measures for Medicaid/Children's Health Insurance Program.

Main Methods:

  • Focuses on the overview of the Pediatric Quality Measures Program (PQMP).
  • Details the program's objectives, development of quality measures, and implementation strategies.
  • Includes analysis of lessons learned and future opportunities for pediatric quality improvement.

Main Results:

  • The PQMP has developed a portfolio of evidence-based pediatric quality measures.
  • These measures are available for use by Medicaid, Children's Health Insurance Program, and other healthcare programs.
  • The program provides a framework for enhancing the Child Core Set of quality measures.

Conclusions:

  • The PQMP is crucial for advancing pediatric health care quality measurement and outcomes.
  • Continued development and implementation of these measures are essential for improving child health services.
  • Lessons learned offer valuable insights for future quality improvement initiatives in pediatric healthcare.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
Methods of Documentation II: POMR01:26

Methods of Documentation II: POMR

The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
399
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
544
Methods of Documentation III: PIE01:21

Methods of Documentation III: PIE

Problem-intervention-evaluation (PIE) is a systematic approach to documentation used in healthcare settings for clinical decision-making and patient care planning. It is a structured approach to organizing patient data based on problems, interventions, and evaluations. Here's a breakdown of its key features and considerations:
1.8K